Parenteral Drugs (India) reports consolidated net loss of Rs 40.84 crore in the March 2017 quarter

Sales decline 12.23% to Rs 47.50 crore

Net Loss of Parenteral Drugs (India) reported to Rs 40.84 crore in the quarter ended March 2017 as against net loss of Rs 42.30 crore during the previous quarter ended March 2016. Sales declined 12.23% to Rs 47.50 crore in the quarter ended March 2017 as against Rs 54.12 crore during the previous quarter ended March 2016.

For the full year,net loss reported to Rs 115.20 crore in the year ended March 2017 as against net loss of Rs 116.55 crore during the previous year ended March 2016. Sales declined 11.73% to Rs 229.74 crore in the year ended March 2017 as against Rs 260.27 crore during the previous year ended March 2016.

ParticularsQuarter EndedYear EndedMar. 2017Mar. 2016% Var.Mar. 2017Mar. 2016% Var.Sales47.5054.12 -12 229.74260.27 -12 OPM %-24.63-58.24 --6.42-12.95 - PBDT-33.44-51.81 35 -100.52-103.58 3 PBT-39.00-54.31 28 -125.40-126.37 1 NP-40.84-42.30 3 -115.20-116.55 1

Powered by Capital Market - Live News